it is an orally bioavailable receptor tyrosine kinase inhibitor with potential antineoplastic activity. it selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet-derived growth factor (PDGFR), Kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation. 
